Ann: Zantrene highly effective in Melanoma preclinical study, page-166

A cardioprotection patent application has already been lodged.

ccRcc. We've been told that the cells are growing slower than expected.

Lung. We've been told this is price sensitive. That doesn't mean a patent issue.

EM AML. The precinical is just a "nice to have" for the eventual NDA; the clinical trials aren't waiting for it.

Melanoma combo. The announcement was originally due by 31 December. Meanwhile there has been a pandemic in the Hunter region with many people required to isolate even if perfectly healthy. No industry has been spared.